Top Ranked Value Stocks to Buy for October 29th
Here are three stocks with buy rank and strong value characteristics for investors to consider today, October 29th:
Pampa Energia S.A. (PAM): This integrated electricity company has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its current year earnings rising 32.8% over the last 90 days.
Pampa Energia S.A. Price and Consensus
Pampa Energia S.A. price-consensus-chart | Pampa Energia S.A. Quote
Pampa Energia has a price-to-earnings ratio (P/E) of 3.5, compared with 17.6 for the industry. The company possesses a Value Score of A.
Pampa Energia S.A. PE Ratio (TTM)
Pampa Energia S.A. pe-ratio-ttm | Pampa Energia S.A. Quote
Sappi Limited (SPPJY): This woodfibre company has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its next year earnings rising 4.6% over the last 60 days.
Sappi Ltd. Price and Consensus
Sappi Ltd. price-consensus-chart | Sappi Ltd. Quote
Sappi has a price-to-earnings ratio (P/E) of 4.04, compared with 10.3 for the industry. The company possesses a Value Score of A.
Sappi Ltd. PE Ratio (TTM)
Sappi Ltd. pe-ratio-ttm | Sappi Ltd. Quote
Jounce Therapeutics, Inc. (JNCE): This clinical-stage immunotherapy company has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its current year earnings rising more than 100% over the last 90 days.
Jounce Therapeutics, Inc. Price and Consensus
Jounce Therapeutics, Inc. price-consensus-chart | Jounce Therapeutics, Inc. Quote
Jounce Therapeutics has a price-to-earnings ratio (P/E) of 2.32, compared with 9 for the industry. The company possesses a Value Score of B.
Jounce Therapeutics, Inc. PE Ratio (TTM)
Jounce Therapeutics, Inc. pe-ratio-ttm | Jounce Therapeutics, Inc. Quote
See the full list of top ranked stocks here.
Learn more about the Value score and how it is calculated here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Sappi Ltd. (SPPJY) : Free Stock Analysis Report
Pampa Energia S.A. (PAM) : Free Stock Analysis Report
Jounce Therapeutics, Inc. (JNCE) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
